Pharmaceutical Grade 1009119-65-6 Daclatasvir Yekurapa Hepatitis C Featured Image

Pharmaceutical Giredhi 1009119-65-6 Daclatasvir Yekurapa Hepatitis C

Tsanangudzo Pfupi:

Kuchena:≧99.0%

Quality Standards:Sezvinodiwa

Chitupa:COA, MOA, MSDS, nezvimwe.

Kugona50Kgs pamwedzi

Sherufu Hupenyu:Makore maviri

Application:inhibitor ye nonstructural protein 5A uye inoshandiswa kurapa hepatitis C

Team Advantage:Ane ruzivo rwekutengesa kunze timu ine nyanzvi yekudzidzira mufekitori

Tumira email kwatiri Dhaunirodha sePDF

Product Detail

FAQ

Product Tags

Productzita	Daclatasvir2HCl
Mashoko anoreva zvakafanana	N,N'-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1 -methylethyl) -2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;BMS 790052
CAS Nha.	1009119-65-6
Chitarisiko	Hupfu hwakachena kusvika hwakachenuruka
Molecular Formula	C₄₀H₅₀N₈O₆.2(HCl)
Molecular Weight	811.81
Usage	Pharmaceutical Giredhi reKutsvagisa chinangwa
Packing	Sekukumbira kwako
Storage	Chengetedza mumidziyo yakasimba, isingapindi chiedza munzvimbo inotonhorera

Daclatasvir2HCl Cas:1009119-65-6
Items	Standard	Results
Hunhu	Hupfu hwakachena kusvika hwakachenuruka	Pale-yellow powder
Mvura yemvura	≦1.0%	0.25%
Kuchena	≧99%	99.7%
Kusachena kumwe chete	≦0.1%	0.06%
Residue pamoto	≦0.1%	Zvinoenderana
Mhedziso	Inopindirana ne-mu-house yakatarwa.

Company Information

√ Management layer's yakazara ruzivo mufekitori uye vane hunyanzvi matekinika vateveri;
√ Hunhu ndiyo inogara ichitarisisa yedu yepamusoro, Yakasimba QC system;
√ makore gumi nerimwe ane ruzivo rwekutengesa kunze timu;
√ Yakazvimirira R&D lab;
√ Mashopu maviri akasainwa kwenguva refu eGMP;
√ Zviwanikwa zvakapfuma zvemafekitori akawanda asina basa epurojekiti yakasarudzika;
√ Yakanyanya Kubudirira inoshanda timu ine inowirirana nzira.
imgaf